Enliven Therapeutics
ELVN
#4135
Rank
A$4.29 B
Marketcap
A$58.68
Share price
0.86%
Change (1 day)
89.49%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of June 2026 : A$0.85 Million

According to Enliven Therapeutics's latest financial reports the company's total debt is A$0.85 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$0.59 M
2024-12-31N/A-100%
2023-12-31A$0.49 M3.59%
2022-12-31A$0.47 M116.42%
2021-12-31A$0.21 M60.61%
2020-12-31A$0.13 M